24
Oct
2023

PANPHARMA

Exhibitor at CPHI Barcelona 2023 stand 2S20, Finished Dosage Formulations
About Us

The Panpharma Group is recognised for its  expertise in the development, production and marketing of injectable medicines for use in healthcare establishments. Since its creation, Panpharma has intentionally specialised in the field of injectable medicines to become one of its leaders. Its wide range of specialities covers the main therapeutic classes, with a particular focus on antibiotic therapy. Panpharma products are manufactured in accordance with the most demanding quality standards, generally at the Group production sites in France and Germany.

  • FR
  • 2015
    On CPHI since
  • 250 - 499
    Employees
Company types
Pharmaceutical company
Contact info
Event information
CPHI Barcelona 2023
  • 24-26 October 2023
  • Fira Barcelona Gran Via, Spain
  • Visit us at stand 2S20, Finished Dosage Formulations

Products Featured at CPHI Barcelona 2023

  • Amoxicillin + Clavulanic acid

    Product Amoxicillin + Clavulanic acid

    Amoxicillin + Clavulanic acid inj.
    brhrbrAmoxicillin + Clavulanic acid 500 MG + 100 MG
  • Amoxicillin + Clavulanic acid

    Product Amoxicillin + Clavulanic acid

    Amoxicillin + Clavulanic acid inj.
    brhrbrAmoxicillin + Clavulanic acid 1 G + 200 MG
  • Cefepime

    Product Cefepime

    Cefepime inj.brhrbrPowder for injection
  • Ciprofloxacine

    Product Ciprofloxacine

    Ciprofloxacine infusionbrhrbr100 mg and 200 mg bags
  • Heparin

    Product Heparin

    Heparin inj. 25 000 IU / 5ML